Engraftment syndrome: double-edged sword of hematopoietic cell transplants
Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants
Engraftment syndrome, the Emperor's new clothes and the artist formerly known as prince
Treatment strategies in patients with AML or high-risk myelodysplastic syndrome relapsed after Allo-SCT
Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts
High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant
Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial
Clinical impact of immunophenotypic remission after allogeneic hematopoietic cell transplantation in multiple myeloma
Hematopoietic SCT in Iranian children 1991–2012
Pegfilgrastim vs filgrastim in PBSC mobilization for autologous hematopoietic SCT: a systematic review and meta-analysis
Cord blood collection and banking from a population with highly diverse geographic origins increase HLA diversity in the registry and do not lower the proportion of validated cord blood units: experience of the Marseille cord blood bank
Major ABO incompatible BMT in children: determining what residual volume of donor red cells can safely be infused following red cell depletion
Physiochemical disparity of mismatched HLA class I alloantigens and risk of acute GVHD following HSCT
Efficiency of allogeneic hematopoietic SCT from HLA fully-matched non-sibling relatives: A new prospect of exploiting extended family search
Pre-transplant diabetes mellitus is a risk factor for non-relapse mortality, especially infection-related mortality, after allogeneic hematopoietic SCT
Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation
Older recipient age is paradoxically associated with a lower incidence of chronic GVHD in Thymoglobulin recipients: a retrospective study exploring risk factors for GVHD in allogeneic transplantation with Thymoglobulin GVHD prophylaxis
Varicella zoster virus reactivation after autologous SCT is a frequent event and associated with favorable outcome in myeloma patients
Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab
Characteristic patterns of relapse after allogeneic hematopoietic SCT for adult T-cell leukemia-lymphoma: a comparative study of recurrent lesions after transplantation and chemotherapy by the Nagasaki Transplant Group
Paediatric reduced intensity conditioning: analysis of centre strategies on regimens and definitions by the EBMT Paediatric Diseases and Complications and Quality of Life WP
Inadvertent transmission of occult CML through allo-SCT
Ponatinib given for advanced leukemia relapse after allo-SCT
A retrospective comparison of BU-fludarabine and BU-CY regimens in elderly patients or in patients with comorbidities who received unmanipulated haploidentical hematopoietic SCT
Important impact of gingival and periodontal conditions on outcomes in SCT recipients
I.v. BU/fludarabine plus melphalan or TBI in unrelated cord blood transplantation for high-risk hematological diseases
Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor cells (HPC) in AL amyloidosis
Treatment of donor-specific antibody-mediated graft rejection by immunochemotherapy, third-party DLI, plasmapheresis and immunoadsorption
Constituting a public umbilical cord blood bank in South Africa